Tag: Novavax
-
A new covid vaccine, Novavax is 89.3% effective in UK, South Africa trials
London, Jan. 29, 2021 (AltAfrica)-UK phase three trials of the experimental Novavax COVID-19 vaccine have found it demonstrated 89.3% efficacy against the virus. Preliminary analysis showed the new UK variant was detected in more than half of the coronavirus cases recorded in the trials, with the vaccine candidate shown to be 95.6% effective against the ... -
Another firm, Novavax starts late-stage trial of covid-19 vaccine in US, Mexico
London, Dec. 29, 2020 (AltAfrica)-Novavax Inc has begun a large late-stage study of its experimental COVID-19 vaccine in the United States, the drug developer said on Monday, after delaying the trial twice due to issues in scaling up the manufacturing process. Novavax’s shot will become the fifth Covid-19 vaccine to enter final-stage testing in the ... -
Novavax vaccine becomes 11th covid-19 vaccines to enter final clinical trials
London, Sep. 25, 2020 (AltAfrica)-US biotech firm Novavax said Thursday it was initiating its final Phase 3 clinical trial for its experimental Covid-19 vaccine. Novavax is the eleventh Covid-19 vaccine candidate to reach the Phase 3 stage globally. The vaccine in question is called NVX-CoV2373, a stable, prefusion protein made from the genetic sequence of ... -
South Africa hosts second Covid-19 vaccine trials in two months
London, August 18, 2020 (AltAfrica)-South Africa is hosting a second covid-19 trials in two months , this time by the United States drug developer Novavax Inc (NVAX.O) which announced on Monday that it had started a mid-stage study of its experimental Covid-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases. ... -
Our covid-19 vaccine produced more antibodies, robust immune response-Novavax
London, August 5, 2020 (AltAfrica)-US biotech company Novavax on Tuesday announced its experimental COVID-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial. AFP reports that the company was given $1.6 billion by the US government last month to develop ... -
Drug firm, Novavax to deliver 100 million doses of covid-19 vaccine by end of the year
London, July 8, 2020 (AltAfrica)-Novavax Inc. said on Tuesday it planned to deliver 100 million doses of its vaccine, potentially by the end of the year in what could be a game changer in the treatment of deadly covid-19 (coronavirus) “We are honored to partner with Operation Warp Speed to move our vaccine candidate forward ...
